tetrandrine has been researched along with Leukemia, T-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Hirano, T; Onda, K; Sugiyama, K; Tanaka, S; Wang, X; Wu, H; Xu, W; Yamada, H | 1 |
| Hirano, T; Liu, ZL; Oka, K; Onda, K; Tanaka, S | 1 |
2 other study(ies) available for tetrandrine and Leukemia, T-Cell
| Article | Year |
|---|---|
Tetrandrine enhances glucocorticoid receptor translocation possibly via inhibition of P-glycoprotein in daunorubicin-resistant human T lymphoblastoid leukemia cells.
Topics: Active Transport, Cell Nucleus; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Benzylisoquinolines; Cell Line, Tumor; Cell Survival; Daunorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Leukemia, T-Cell; Receptors, Glucocorticoid; Signal Transduction | 2020 |
Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
Topics: Alkaloids; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Daunorubicin; Drug Resistance, Multiple; Flow Cytometry; Humans; Leukemia, T-Cell; Tumor Cells, Cultured | 2003 |